Therefore, there may be significant value in targeting T lymphocytes to treat or prevent neuropsychiatric disorders.
← all excerpts
Single-cell transcriptome-wide Mendelian randomization during CD4<sup>+</sup> T cell activation reveals immune-mediated mechanisms and drug targets for neuropsychiatric disorders.
1
—
—